Jun 30, 2021

Revolution Medicines Q2 2021 Earnings Report

Total Revenue
$8.7M
Previous year: $10M
-13.2%
EPS
-$0.6
Previous year: -$0.46
+30.4%
Gross Profit
-$37.2M
Cash and Equivalents
$196M
Free Cash Flow
-$35.4M
Total Assets
$774M

Revolution Medicines

Revolution Medicines